首页> 外文OA文献 >PCN12 IMPACT OF ADJUVANT CHEMOTHERAPY WITH DOCETAXEL FOR EARLY BREAST CANCER: COST-EFFECTIVENESS ANALYSIS (CEA) OF A DOCETAXEL, DOXORUBICIN AND CYCLOPHOSPHAMIDE REGIMEN (TAC) VERSUS 5-FLUOROURACIL, DOXORUBICIN AND CYCLOPHOSPHAMIDE (FAC) IN FRANCE

【2h】

PCN12 IMPACT OF ADJUVANT CHEMOTHERAPY WITH DOCETAXEL FOR EARLY BREAST CANCER: COST-EFFECTIVENESS ANALYSIS (CEA) OF A DOCETAXEL, DOXORUBICIN AND CYCLOPHOSPHAMIDE REGIMEN (TAC) VERSUS 5-FLUOROURACIL, DOXORUBICIN AND CYCLOPHOSPHAMIDE (FAC) IN FRANCE

机译：PCN12辅助化疗与DOCETAXEL对早期乳腺癌的影响：DOCETAXEL，阿霉素和环磷酰胺（TAC）与5-氟尿嘧啶，阿霉素，环磷酰胺和环磷酰胺的成本效益分析（CEA）

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Miadi-Fargier H; Le Pen C; Woronoff-Lemsi MC; Guastalla JP; Pivot X; Roché H; Pinguet F; Favier B; Gligorov J; Debrix I; Spielmann M; Antoine EC; Cadilhac M; De Pouvourville GA;
展开▼
作者单位

展开▼
年度 2005
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. 环磷酰胺、阿霉素、5-氟尿嘧啶方案与紫杉醇、顺铂方案治疗晚期乳腺癌的疗效比较 [J] . 林显敢, 谢德荣, 姚和瑞, 癌症（英文版） . 2003,第004期
2. Toxicity and health-related quality of life in breast cancer patients receiving adjuvant docetaxel, doxorubicin, cyclophosphamide (TAC) or 5-fluorouracil, doxorubicin and cyclophosphamide (FAC): impact of adding primary prophylactic granulocyte-colony stimulating factor to the TAC regimen [J] . M. Martín, A. Lluch, M. A. Seguí, Annals of Oncology . 2006,第8期

机译：接受多西他赛，阿霉素，环磷酰胺（TAC）或5-氟尿嘧啶，阿霉素和环磷酰胺（FAC）辅助治疗的乳腺癌患者的毒性和健康相关的生活质量：在TAC方案中添加主要预防性粒细胞集落刺激因子的影响
3. Cost-effectiveness analysis of adjuvant therapy for node positive breast cancer in Korea: docetaxel, doxorubicin and cyclophosphamide (TAC) versus fluorouracil, doxorubicin and cyclophosphamide (FAC). [J] . Lee SG, Jee YG, Chung HC, Breast cancer research and treatment. . 2009,第3期

机译：韩国结节阳性乳腺癌辅助治疗的成本效益分析：多西他赛，阿霉素和环磷酰胺（TAC）与氟尿嘧啶，阿霉素和环磷酰胺（FAC）。
4. Toxicity and health-related quality of life in breast cancer patients receiving adjuvant docetaxel, doxorubicin, cyclophosphamide (TAC) or 5-fluorouracil, doxorubicin and cyclophosphamide (FAC): impact of adding primary prophylactic granulocyte-colon [J] . Martin M, Lluch A, Segui MA, Annals of oncology: official journal of the European Society for Medical Oncology . 2006,第8期

机译：接受多西他赛，阿霉素，环磷酰胺（TAC）或5-氟尿嘧啶，阿霉素和环磷酰胺（FAC）辅助治疗的乳腺癌患者的毒性和健康相关的生活质量：添加初级预防性粒细胞结肠的影响
5. Use of Laser Photomodulation in the Evolution of Oral Mucositis Associated to Cyclophosphamide, Methotrexate, 5-Fluouracil - CMF in 5 Fluouracil + Adriamycin + Cyclophosphamide - FAC Chemotherapy Protocols in Patients with Breast Cancer [C] . Maria de Fatima Lima Ferreira, Fabiola Bastos de Carvalho, Susana C. P. S. de Oliveira, Mechanisms for low-light therapy VIII . 2013

机译：激光光调节在5种氟尿嘧啶+阿霉素+环磷酰胺-FAC化疗方案中与环磷酰胺，甲氨蝶呤，5-氟尿嘧啶-CMF相关的口腔黏膜演变中的应用
6. Comparison of the effectiveness and toxicity of neoadjuvant chemotherapy regimens capecitabine/epirubicin/cyclophosphamide vs 5-fluorouracil/epirubicin/cyclophosphamide followed by adjuvant capecitabine/docetaxel vs docetaxel in patients with operable breast cancer [O] . Minmin Zhang, Wei Wei, Jianlun Liu, 2016

机译：在可手术乳腺癌患者中新辅助化疗方案卡培他滨/厄比霉素/环磷酰胺与5-氟尿嘧啶/厄比霉素/环磷酰胺再辅以卡培他滨/多西他赛与多西他赛的疗效和毒性比较
7. CN3 COMPARISON OFTHE COST-EFFECTIVENESS OF SIX CYCLES OFTAXOTERE, DOXORUBICIN, CYCLOPHOSPHAMIDE (TAC) VERSUS SIX CYCLES OF FLUOROURACIL, DOXORUBICIN, CYCLOPHOSPHAMIDE (FAC) INTHE ADJUVANT SETTING OF NODE POSITIVE BREAST CANCERWITH PRIMARY AND SECONDARY G-CSF PROPHYLAXIS [O] . Mittmann N, Koo M, Alloul K, 2008

机译：CN3比较六环紫杉醇，阿霉素，环磷酰胺（TAC）相对于六环氟尿嘧啶，阿霉素，环磷酰胺（FAC）对结直肠癌的抗凝作用，以及对结点的多巴利多酚

PCN12 IMPACT OF ADJUVANT CHEMOTHERAPY WITH DOCETAXEL FOR EARLY BREAST CANCER: COST-EFFECTIVENESS ANALYSIS (CEA) OF A DOCETAXEL, DOXORUBICIN AND CYCLOPHOSPHAMIDE REGIMEN (TAC) VERSUS 5-FLUOROURACIL, DOXORUBICIN AND CYCLOPHOSPHAMIDE (FAC) IN FRANCE

著录项

引文网络

相似文献

相关主题

期刊订阅